http://www.healthiertalk.com/big-pha...d-history-4911
Big Pharma's new drug has a twisted history
By Dr. Allan Spreen on 11/09/2011
Quote:
|
Big Pharma and Big Tobacco share the same bed
|
_____________________
just FYI - not much gets as bad as the mecamylamine hcl/Inversine debacle which I've been following for many years now ever since it was trialed in young children with Tourette's syndrome and a staffer from Layton BioScience was actually posting on some of the TS forums at the time attempting to market their medication. That was very strange!
Anyway, R.J. Reynolds/ Layton BioScience / Targacept / now I think they are Targacept/AstraZeneca
They keep changing their names and therefore keep changing their target population. smokers, tic disorders, depression, adhd etc etc Makes me sick.
Quote:
http://www.ncbi.nlm.nih.gov/pubmed/11556635
J Am Acad Child Adolesc Psychiatry. 2001 Sep;40(9):1103-10.
Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder.
Silver AA, Shytle RD, Sheehan KH, Sheehan DV, Ramos A, Sanberg PR.
Source
University of South Florida College of Medicine, Tampa 33613, USA.
|
Quote:
|
Financial Disclosure: RDS, AAS, and PRS are inventors on a patent owned by the University of South Florida, which covers the use of nicotinic receptor antagonists for the treatment of nicotine-responsive neuropsychiatric disorders. RDS, AAS, PRS, and DVS have served as scientific consultants for Layton BioScience, Inc., who own the tradename and marketing rights to mecamylamine (Inversine®). PRS has also served on the board of directors for Layton BioScience, Inc.
|
Quote:
Funded by University of South Florida I-4 Corridor Project
Layton BioScience, Inc.
|
RDS = R. Douglas Shytle
AAS = Archie A. Silver
DVS = David V. Sheehan
PRS = Paul R. Sanberg